x

Search for a research project

* (*) mandatory field

55 Result(s)

Sort by

Funded by an IRDiRC member =

Research projects

AUSTRIA

WIEN
WIEN

3D 2HG mapping as biomarker for IDH-mutation in glioma
Medizinische Universität Wien
Exzellenzzentrum für Hochfeld-MR

AUSTRIA

WIEN
WIEN

Disease progression and treatment-induced alterations in glioblastoma
Allgemeines Krankenhaus der Stadt Wien
Klinisches Institut für Neurologie

AUSTRIA

WIEN
WIEN

Fibroblast Growth Factor Receptor 4 in Glioblastoma
Medizinische Universität Wien
Institut für Krebsforschung

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Development of a new drug therapy for glioblastoma
Parc scientifique et technologiques de Luminy
PHARMAXON

GERMANY

Berlin
BERLIN

Molecular causes ans target molecules in tumor progression of malignant brain tumors
Charité - Universitätsmedizin Berlin (CCM)
Institut für Neuropathologie

GERMANY

Nordrhein-Westfalen
DÜSSELDORF

Targeting HOTAIRM1 in Glioblastoma Multiforme
Universitätsklinikum Düsseldorf
Hirntumor-Referenzzentrum der DGNN

ITALY

LAZIO
ROMA

Funded by an IRDiRC memberTHERAGLIO: Microbubble driven multimodal imaging and theranostics for gliomas - IT
Università degli Studi di Roma Tor Vergata
Dipartimento di Scienze e Tecnologie Chimiche

PORTUGAL

CENTRO
BRAGA

SPAIN

Castilla - León
SALAMANCA

SPAIN

Cataluña
LLEIDA

Funded by an IRDiRC memberRegulation of the autophagic flux in Glioblastoma: towards the identification of novel therapeutical strategies
Instituto de Investigación Biomédica de Lleida (IRBLLEIDA)
Señalización por calcio y diferenciación neuronal

SPAIN

País Vasco
SAN SEBASTIÁN

SWEDEN

Landstinget i Uppsala län
UPPSALA

AUSTRIA

WIEN
WIEN

7 Tesla MR spectoscopy in diffusely infiltrating gliomas
Medizinische Universität Wien
Exzellenzzentrum für Hochfeld-MR

GERMANY

Baden-Württemberg
HEIDELBERG

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

CANADA

Québec
MONTRÉAL

Funded by an IRDiRC memberIdentification and characterization of genes involved in the genesis and progression of pediatric astrocytomas
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

CANADA

Québec
MONTRÉAL

Funded by an IRDiRC memberRole of chromatin remodeling in the genesis of pediatric and young adult astrocytomes
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

CANADA

Québec
MONTRÉAL

Funded by an IRDiRC memberThe ICHANGE (International CHildhood Astrocytomas iNtegrated Genomics and Epigenomics) Consortium
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

SPAIN

Galicia
SANTIAGO DE COMPOSTELA

Funded by an IRDiRC memberMetabolism of tumor cells and AMPK. Achilles heel and new therapeutic target in cerebral astrocytomas
CiMUS - Centro de Investigación en Medicina Molecular y Enfermedades Crónicas
Neuroendocrinology, energy homeostasis, metabolism and cancer

AUSTRIA

WIEN
WIEN

Magnetic Resonance Fingerprinting of Patients with Gliomas
Medizinische Universität Wien
Exzellenzzentrum für Hochfeld-MR

GERMANY

Nordrhein-Westfalen
MÜNSTER

Cellular and molecular mechanisms of glioma invasion
Institut für Neuropathologie der Medizinischen Fakultät Münster
Institut für Neuropathologie

PORTUGAL

SUL
LISBOA

Role of protein kinase WNK2 as a tumour suppressor gene in malignant gliomas
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Unidade de Investigação e Desenvolvimento

SPAIN

Castilla - La Mancha
TOLEDO

Funded by an IRDiRC memberStudy of gliomas: analysis of large-scale sequencing, molecular techniques, imaging and clinical data analysis. Generation of a diagnostic platform
Infomédula - Fundación del Hospital Nacional de Parapléjicos
Fundación del Hospital Nacional de Parapléjicos para la Investigación y la Integración

SPAIN

Madrid
MADRID

Funded by an IRDiRC memberInduction of preoperative plasticity in brain tumors of eloquent areas
IdISSC - Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
Área de Neurociencias

SWEDEN

Landstinget i Uppsala län
UPPSALA

Molecular mechanisms of the origine of glioma development
Uppsala Universitet
Department of Immunology, Genetics and Pathology

UNITED KINGDOM

Nottinghamshire
NOTTINGHAM

UNITED KINGDOM

West Midlands
BIRMINGHAM

ITALY

CAMPANIA
NAPOLI

Cytogenetic characterization of central nervous system tumors
P.S.I. "Elena d'Aosta"
U.O.C. Servizio di Genetica

PORTUGAL

CENTRO
BRAGA

FRANCE

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

ITALY

LOMBARDIA
MILANO

RARECARE: surveillance of rare cancers in Europe (coordination)
Fondazione IRCCS Istituto Nazionale dei Tumori
S.S. di Epidemiologia Valutativa

UNITED KINGDOM

Greater London
LONDON

Funded by an IRDiRC memberUK Infrastructure for Large-scale Clinical Genomics Research
Barts and The London School of Medicine and Dentistry
William Harvey Research Institute

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

Funded by an IRDiRC memberNewcastle University Single Cell Functional Genomics Unit (NUSCU)
Newcastle University
Institute of Genetic Medicine

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

EPOC: European paediatric oncology off-patent medicines consortium (coordination)
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

Multicentric Research projects